NeoGenomics Reports 159% Revenue Growth to $63.1 Million and Strong Gains in Profitability in the Second Quarter of 2016

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. LVS
6. SAP
7. CSX
8. LRCX
9. KNX
10. SPCX

Go back to NeoGenomics Reports 159% Revenue Growth to $63.1 Million and Strong Gains in Profitability in the Second Quarter of 2016

BTIG Downgrades Neogenomics (NEO) to Neutral

July 27, 2016 7:34 AM EDT

BTIG downgraded Neogenomics (NASDAQ: NEO) from Buy to Neutral and removed its price target. Analyst Sean Lavin sees less compelling risk reward.

"Shares have risen 70% in less than a year. Our Buy thesis had been predicated on continued share gains, stable reimbursement, and... More

NeoGenomics (NEO) Tops Q2 EPS by 1c

July 26, 2016 8:18 AM EDT

NeoGenomics (NASDAQ: NEO) reported Q2 EPS of $0.04, $0.01 better than the analyst estimate of $0.03. Revenue for the quarter came in at $63.1 million versus the consensus estimate of $61.07 million.

For earnings history and earnings-related data on NeoGenomics (NEO) click here.

... More